The micro- and nanotechnology based biosensing principles open up new possibilities towards the development and realisation of robust, user-friendly and cost-effective in-vitro diagnostic platforms. Furthermore, label-free and multianalyte detection is envisioned to allow more accuracy and higher throughput in clinical diagnostic. The bioanalytical systems are expected to integrate the nanoscale transducers with interface chemistry, and bio-receptors as well as the microfluidics, control software and hardware. The final goal of this work is to develop nanopore based multiparametric biosensing platform, applicable for label-free detection of blood marker proteins of cardiovascular symptoms.
|Number of pages||4|
|Publication status||Published - Jan 1 2012|
|Event||26th European Conference on Solid-State Transducers, EUROSENSOR 2012 - Krakow, Poland|
Duration: Sep 9 2012 → Sep 12 2012
- Blood diagnostics
- Nanopore sensing
ASJC Scopus subject areas